Phase 3
Completed N=539
Study of Pitavastatin in Elderly Patients With Primary Hypercholesterolemia or Combined Dyslipidemia
Hypercholesterolemia · Dyslipidemias
Source: ClinicalTrials.gov NCT00330876 ↗
Enrolled (actual)
539
Serious AEs
10.8%
Results posted
Jan 2010
Primary outcomePrimary: Change From Baseline in LDL-C — -43.18; -44.26 percent change
Summary
This is an open-label extension study of NK-104-306 (NCT00257686) for elderly patients with hypercholesterolemia or combined dyslipidemia.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change From Baseline in LDL-C |
-43.18; -44.26 | — |
| SECONDARY Change From Baseline in Total Cholesterol |
-28.27; -30.54 | — |
Eligibility Criteria
Inclusion Criteria
- Greater than or equal to 65 years of age
- Primary hypercholesterolemia
- Combined dyslipidemia
- Completed study NK-104-306 (NCT00257686)
Exclusion Criteria
- Failed to complete study NK-104-306(NCT00257686)
Data sourced from ClinicalTrials.gov (NCT00330876). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.